FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Webber

Research Profile

Procedures

Microbial Sensitivity Tests

Chemicals & Drugs

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Nick G Coldham; Mark Webber; Martin J Woodward; Laura J V Piddock
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli.
Mark Webber; Luke P Randall; Sue W Cooles; Martin J Woodward; Laura J V Piddock
Triclosan resistance in Salmonella enterica serovar Typhimurium.
Mark Webber; Nick G Coldham; Martin J Woodward; Laura J V Piddock
Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Webber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Nick G Coldham; Mark Webber; Martin J Woodward; Laura J V Piddock
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli.
The Journal of antimicrobial chemotherapy 2010;65(8):1655-63.
2008: Mark Webber; Luke P Randall; Sue W Cooles; Martin J Woodward; Laura J V Piddock
Triclosan resistance in Salmonella enterica serovar Typhimurium.
The Journal of antimicrobial chemotherapy 2008;62(1):83-91.
2008: Mark Webber; Nick G Coldham; Martin J Woodward; Laura J V Piddock
Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium.
The Journal of antimicrobial chemotherapy 2008;62(1):92-7.
2007: Luke P Randall; Sue W Cooles; Nick G Coldham; E G Penuela; A C Mott; Martin J Woodward; Laura J V Piddock; Mark Webber
Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence.
The Journal of antimicrobial chemotherapy 2007;60(6):1273-80.
2007: Kimon A G Karatzas; Mark Webber; Frieda Jorgensen; Martin J Woodward; Laura J V Piddock; Tom J Humphrey
Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness.
The Journal of antimicrobial chemotherapy 2007;60(5):947-55.
2006: Anthony M Buckley; Mark Webber; Sue W Cooles; Luke P Randall; Roberto M La Ragione; Martin J Woodward; Laura J V Piddock
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis.
Cellular microbiology 2006;8(5):847-56.
2006: Mark Webber; Anthony M Buckley; Luke P Randall; Martin J Woodward; Laura J V Piddock
Overexpression of marA, soxS and acrB in veterinary isolates of Salmonella enterica rarely correlates with cyclohexane tolerance.
The Journal of antimicrobial chemotherapy 2006;57(4):673-9.
2006: Andrew M Bailey; Mark Webber; Laura J V Piddock
Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli.
Antimicrobial agents and chemotherapy 2006;50(3):1071-4.
2005: Mark Webber; Ashraf Talukder; Laura J V Piddock
Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.
Antimicrobial agents and chemotherapy 2005;49(10):4390-2.
2003: Laura J V Piddock; M M Johnson; Mark Webber
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
The Journal of antimicrobial chemotherapy 2003;52(3):500-2.
2003: Mark Webber; Laura J V Piddock
The importance of efflux pumps in bacterial antibiotic resistance.
The Journal of antimicrobial chemotherapy 2003;51(1):9-11.
2002: Laura J V Piddock; Yu Fang Jin; Mark Webber; Martin J Everett
Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2002;46(7):2276-8.
2001: Mark Webber; Laura J V Piddock
Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.
Antimicrobial agents and chemotherapy 2001;45(5):1550-2.